[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Michel Doepke [@doepke_michel](/creator/twitter/doepke_michel) on x 4936 followers Created: 2025-07-18 11:03:15 UTC $BMY Announces Topline Results from Phase X INDEPENDENCE Trial for Reblozyl (luspatercept-aamt) in Adult Patients with Myelofibrosis-Associated Anemia - did not meet its primary endpoint.  XXXXX engagements  **Related Topics** [$bmy](/topic/$bmy) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/doepke_michel/status/1946163853567414770)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Michel Doepke @doepke_michel on x 4936 followers
Created: 2025-07-18 11:03:15 UTC
$BMY Announces Topline Results from Phase X INDEPENDENCE Trial for Reblozyl (luspatercept-aamt) in Adult Patients with Myelofibrosis-Associated Anemia - did not meet its primary endpoint.
XXXXX engagements
Related Topics $bmy stocks healthcare
/post/tweet::1946163853567414770